Brainstorm Cell Therapeutics Inc
OTC:BCLI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Brainstorm Cell Therapeutics Inc
OTC:BCLI
|
US |
|
S
|
Stryker Corp
XMUN:SYK
|
US |
|
T
|
Tyler Technologies Inc
SWB:TYP
|
US |
|
P
|
Pernod Ricard SA
F:PER
|
FR |
|
M
|
Mitsubishi Estate Co Ltd
XMUN:MES
|
JP |
|
L
|
Lloyds Banking Group PLC
XMUN:LLD
|
UK |
|
Strongpoint ASA
OSE:STRO
|
NO |
|
Hims & Hers Health Inc
F:82W
|
US |
|
S
|
Salesforce Inc
XMUN:FOO
|
US |
|
ImpediMed Ltd
ASX:IPD
|
AU |
|
M
|
Mitsubishi Estate Co Ltd
F:MES
|
JP |
|
MS&AD Insurance Group Holdings Inc
F:59M
|
JP |
Bankruptcy Probability
Brainstorm Cell Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Brainstorm Cell Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Brainstorm Cell Therapeutics Inc
OTC:BCLI
|
9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
504.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
193.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
79.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Brainstorm Cell Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Brainstorm Cell Therapeutics Inc has total debt of 1.2m USD. This includes both short-term (1.2m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.